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ABSTRACT
Background and Aims Addiction is associated with severe economic and social consequences and personal tragedies,
the scientific exploration of which draws upon investigations at the molecular, cellular and systems levels with a wide
variety of technologies. Magnetic resonance imaging (MRI) has been key to mapping effects observed at the microscopic
and mesoscopic scales. The range of measurements from this apparatus has opened new avenues linking neurobiology
to behaviour. This review considers the role of MRI in addiction research, and what future technological improvements
might offer. Methods A hermeneutic strategy supplemented by an expansive, systematic search of PubMed, Scopus
and Web of Science databases, covering from database inception to October 2015, with a conjunction of search terms
relevant to addiction and MRI. Formal meta-analyses were prioritized. Results Results from methods that probe brain
structure and function suggest frontostriatal circuitry disturbances within specific cognitive domains, some of which
predict drug relapse and treatment response. New methods of processing imaging data are opening opportunities for
understanding the role of cerebral vasculature, a global view of brain communication and the complex topology of the
cortical surface and drug action. Future technological advances include increases in MRI field strength, with concomitant
improvements in image quality. Conclusions The magnetic resonance imaging literature provides a limited but
convergent picture of the neurobiology of addiction as global changes to brain structure and functional disturbances to
frontostriatal circuitry, accompanied by changes in anterior white matter.
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INTRODUCTION
Without doubt, the technology to image the structure and
function of the brain non-invasively (referred to collectively
as neuroimaging) has transformed our understanding of
neurological and psychiatric disorders, arguably setting
them on a convergent course. Addiction research has
benefited greatly from the resurgence of experimental
psychology and psychiatry that has been made possible
by neuroimaging. Existing reviews of the extant literature
have identified some of the major cortical and subcortical
components of the complex neurobiological circuitry that
forms the substrate for the compulsive seeking, excessive
consumption and negative emotions accompanying
withdrawal that characterize addictive behaviours. In
short, current cumulative knowledge implicates
dopaminergic pathways with origins in the ventral
tegmental area connected to the prefrontal cortex via the
limbic system, in particular the nucleus accumbens,
amygdala, ventral pallidum and hippocampus [1–5].
Measuring and understanding the consequences of the
chronic consumption of alcohol by radiological
examination has been of interest since at least the 1950s,
with generalized atrophy of the brain depicted by
pneumoencephalography [6,7]. Modern neuroimaging
encompasses a large range of techniques based on a variety
of physical phenomena. Although the contribution of
radioisotope imaging has been highly significant in the
discovery andmapping of the role of dopamine in addiction
[8], magnetic resonance imaging (MRI) is the mainstay of
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addiction imaging research due its safety, absence of
radioactivity and flexibility in the information obtained.
Advances in MRI technology continue, along with
postprocessing algorithms that are creating new
representations of MRI data, refreshing the vocabulary
describing the brain in health and disorder.
Here, our current knowledge of the neurobiology of
addiction is summarized with data from human studies
using established methodologies for measuring the
structure and function of the brain with MRI. The field is
now sufficiently mature that distilling the germane
features from the literature can be undertaken by
meta-analysis, and where available these accounts will be
drawn upon. With a contemporaneous account of the
literature consolidated, recent efforts with new methods
and technologies are examined for future opportunities
that will increase the breadth of knowledge on the
neurobiology of addiction.
METHODS
The objective of this review was a synthesis of the peer-
reviewed literature of the current state of the art of neuroim-
aging, specifically MRI, in the context of addiction research
with a view to projecting future developments in this area.
The primary approach was to assemble the relevant
literature with a hermeneutic strategy [9]. Here, a small
number of seminal papers [1–5] were identified for review
followed by open-ended searches to locate relevant papers
using the citation and author-tracking functionality of
the PubMed (http://www.ncbi.nlm.nih.gov/pubmed),
Scopus (http://www.scopus.com) and Web of Science
(https://apps.webofknowledge.com/) on-line databases,
and refining the narrative as the content of the evidence
became apparent. Additional, expansive explorations were
made using a conjunction of the search terms ‘addiction’ or
‘dependency’ and ‘MRI’ or ‘magnetic resonance imaging’
or ‘neuroimaging’, again followed by open-ended searches
of citations and authors. Searching was terminated once a
particular line of argument was substantiated. Any formal
meta-analyses that were revealed by these strategies
were prioritized in terms of their contribution to the
narrative. Key, highly-cited papers on specific resources,
methodologies and techniques acquired from previous
qualitative reviews by the authors were also included.
Throughout the search processes no limit was placed
on the earliest papers returned to permit a historical
perspective. However, the most recent papers included
were established by the time of the searches as of
October 2015. Only papers with human participants were
included. Studies with negative results were incorporated
where the complementary, positive results were not
supported by overwhelming evidence.
Current structural and functional MRI findings
Brain anatomy and structure
The most prevalent method for measuring brain structure,
voxel-based morphometry (VBM) [10], draws upon the
contrast between grey and white matter in high-resolution
MRI to estimate tissue volumes, as well as ventricular
volumes that are filled with cerebrospinal fluid (CSF).
Following digital alignment of these tissue maps, statistical
comparisons that search, for example, for significant case–
control differences at every intra-cerebral location are
possible in what is often termed a ‘whole-brain’ analysis.
Qualitatively, almost all drugs of abuse are associated
with reductions in cortical volume, especially in the frontal
lobes, reiterating the general observations made in the
earliest studies. This is accompanied by increases in the
volumes of subcortical structures associated with
dependency on stimulants such as cocaine and metham-
phetamine [11]. A formal meta-analysis of the whole-brain
VBM literature partly supports this view [12] with
decreases in volumes in prefrontal cortex, but also in the
insula, inferior frontal gyrus, pregenual anterior cingulate
and anterior thalamus with, notably, the decline in grey
matter in frontal regions related to duration of dependency.
However, changes in the subcortices are not seen across
the literature, which may be due to inconsistent results in
the primary literature or a bias in the sensitivity of the
VBM methodology in these regions of the brain [12].
Several studies to date show that different addiction
groups have reduced grey matter volume compared to
healthy controls in regions of the brain targeted by the
specific drug of abuse, including alcohol [13], cocaine
[14,15], amphetamine [16] and nicotine [17–19].
However, the approaches taken in these studies appear to
neglect the contribution to structural deficits that arise
from relapse, treatment outcome and abstinence; it is
unclear how former addicts remain abstinent even with
severe structural deficits in brain regions implicated in
addiction [20]. Furthermore, there is evidence for shared
structural deficits between addict and non-addict popula-
tions. Abnormalities in frontostriatal brain systems in both
stimulant-dependent individuals and their biological
siblings who have no history of chronic drug abuse [21]
potentially devalue the clinical significance of these
outcome measures for addiction.
White matter differences have been difficult to observe
with whole-brain VBM in heavy cannabis users [22] and
cocaine addiction addicts [23]. Detections of white matter
changes have been associatedwith amphetamine use, with
results equivocal concerning the direction and location of
case–control differences [1]. This suggests that if addiction
does lead to changes in white matter, they occur most
probably at the microscopic scale without consistent
observable changes in volume.
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White matter microstructure
A complementary MRI technique probing brain structure is
imaging the diffusion of water. Compared to grey matter,
water diffusion has restricted motion in white matter due to
the alignment of neuronal fibres. Using this observation,
estimates of the trajectories of whitematter tracts are possible
with a technique known as diffusion tensor imaging (DTI).
DTI produces some of the most spectacular maps of the
so-called human connectome, and has led to changes in
our understanding of the way the brain is organized in
the healthy population [24]. However, there remain some
analytical issues that temper confidence in DTI, particu-
larly with estimation of tracts that span large distances
[25,26]. An overview of measurable DTI effects in chronic
alcoholics draws a picture of reductions in white matter
integrity in anterior parts of the brain, particularly the
supratentorial and infratentorial white matter bundles,
which may be ascribed to myelin degradation [27].
However, amore recent studyof alcoholics appears to show
an opposite pattern of abnormalities [28].
A simplified alternative to reconstructing white matter
tracts with DTI is to measure the local direction of water
diffusion and the speed of diffusion with the scalar values of
fractional anisotropy (FA) and mean diffusivity (MD), respec-
tively. While visualization of white matter connectivity is
sacrificed, the established statistical apparatus for testing
whole-brain effects can be deployed in the sameway as VBM.
The corpus callosum has come under scrutiny for its
role in alcohol addiction from early pathological reports
of its reduced volume. A review of DTI data specifically
within the corpus callosum [29] points towards decreased
FA and increased MD in alcoholics, and a similar reduction
in FA in cocaine addicts [23]. In both cases, the duration of
addictive behaviours appears to amplify these effects,
pointing towards a decrease in the density of fibre bundles.
These results are in the absence of gross morphological
brain changes, indicating that DTI may have enhanced
sensitivity relative to VBM.
Reductions in FA in the corpus callosum, as well as the
thalamic radiation and inferior longitudinal fasciculus,
have also been observed in opiate addicts [30]. Again, ef-
fects associated with duration of drug use were significant,
converging with evidence from an earlier study [31].
However, contrary to the regional data, FA in the corpus
callosum did not differ between cocaine addicts and control
participants when whole-brain testing for differences.
Differences were found in FA in the inferior frontal lobe
and increases in the anterior cingulate [23]. Other forms
of addiction have also been studied with DTI, but without
revealing any common underlying pathology. Case–control
differences of individuals prone to obsessive gaming on the
internet showed increases in FA in the thalamus and
posterior regions of the cingulate cortex that do not overlap
with the more frontal differences observed with drug
addictions [32].
Functional response to cognitive tasks
Functional MRI (fMRI) measures brain activity via the
blood oxygenation level-dependent (BOLD) endogenous
contrast [33], exploiting the distinct magnetic properties
of oxygenated and deoxygenated blood for its detection by
MRI. As neuronal activity requires oxygen, the BOLD
signal is therefore related indirectly to local functional
processing. Experiments with fMRI often induce specific
cognitive processes with appropriate stimuli, highlighting
the regions and circuits that are involved.
Common tomuch addictive behaviour is cue–reactivity,
in which exposure to stimuli induces craving as a
consequence of Pavlovian conditioning [34]. A descriptive
overview of the literature suggests increased activation
in addicted individuals, particularly in prefrontal
and orbitofrontal regions [35]. However, a formal meta-
analysis of fMRI data [36] reports that regions of increased
cue–reactivity converged in nicotine, alcohol and cocaine
addicts to the anterior cingulate cortex, amygdala and
ventral striatum, which includes the nucleus accumbens.
A concurrent meta-analytical investigation of fMRI and
positron emission tomography (PET) studies broadly
confirms this pattern [37]. Interestingly, several of these
areas have also been observed by meta-analysis as being
associated with food cues [38] and, to a lesser extent, in
addictive behaviours towards internet gaming [39].
Inhibitory control is the suppression of pre-potent
actions and resisting interference from extraneous stimuli
to engage instead in goal-directed behaviours. In cocaine
addicts, increased activity was observed in prefrontal and
cingulate cortices, inferior frontal regions and cerebellum
during response inhibition, irrespective of whether or not
the action was inhibited successfully [40]. Conversely, in
opiate addicts, activity in anterior cingulate cortex was
attenuated during unsuccessful inhibition of response [41].
Functional MRI tasks invoking emotional responses
activate the limbic system [42], which is increased in
alcoholics when comparing negative to positive valenced
images [43], primarily in insula, inferior frontal, medial
temporal and parahippocampal regions. A similar task con-
trast in cocaine addicts also resulted in increased activation,
but in parietal and medial prefrontal regions [44].
Current innovations
Imaging the structure and function of brain has identified
key networks associated with addiction. Data processing
algorithms are deriving new information from existing
data and offering a broader view of the biology of addiction,
mechanisms of drug action and potential applications of
imaging to clinical management.
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Brain perfusion
MRI techniques can supplant existingmeasurements using
radioactive tracers, with concomitant improvements in
participant safety. One such example is the measurement
of blood perfusion with arterial spin labelling (ASL).
Arterial blood is ‘labelled’ magnetically as it enters the
brain. As the blood perfuses the tissues, the labelling alters
the local tissue signal. Subtracting the labelled image from
an unlabelled image produces a map of perfusion [45].
Drug dependence results frequently in cardiovascular
problems that make up a significant proportion of
drug-related morbidity [46] and effects cognitive perfor-
mance through cerebral hypoperfusion [47]. Heart disease
is well-known in chronic alcoholism [48], and the perfusion
of frontal and parietal grey matter measured in case–-
control studies by ASL in alcoholics is significantly lower
[49]. Similarly, in opiate users administration of heroin
reduces perfusion in the insula, anterior cingulate and
medial prefrontal cortices [50], and in a separate study
more severe depressive symptoms are associated with
reduced perfusion in prefrontal and middle frontal
regions [51]. Internet gaming addiction demonstrates a
more mixed picture, with both increases and decreases in
perfusion widespread throughout the neocortex [52],
suggesting a quite different disorder from that engendered
by substance dependency.
The functionally connected brain
It has become known recently that brain networks not
only appear in response to stimuli but are, in fact,
configured and poised continually to receive input [53].
This remarkable transformation in the way the brain is
conceived has had a profound effect on experimental
design, with interest now on the so-called ‘resting-state’
or, more precisely, data acquisition in the absence of any
specific external stimulus.
Functional connectivity between two or more brain
regions refers frequently to the Pearson’s correlation
coefficient between corresponding BOLD time–series. A
hypothesis-driven approach is to select a particular region,
known as the ‘seed’, and then calculate the correlation
between this region and everyother locationwithin a brain
network, testing subsequently for statistical differences.
Prevailing ideas on the neurocircuitry of addiction
have centred on dopaminergic pathways in the
mesocorticolimbic pathway, with projections to the
prefrontal cortex. This is an inviting target for seed-based
connectivity analysis, and the literature has become
rapidly populated with studies of this type (reviewed in
[54]). In general, alterations to this circuit are found
consistently across addictions to different drugs, although
the direction of this effect is at times inconsistent, particu-
larly between striatal regions and the prefrontal cortex.
If functional connections between all regions are
calculated they can be represented as a network
constructed from nodes (brain regions) linked by edges
(significant functional connectivity). Topological properties
of the network include measures of the global efficiency of
communication, local concentration of connections,
overall organizational structure, and so on [55].
Application of this approach to addiction research is
under-represented to date, although preliminary data
indicate some sensitivity.
In opiate users, networks had increased connectivity
between neighbouring brain regions with an increased
number of connections in regions overlapping with the
mesocorticolimbic pathway; namely, components of the
striatum and prefrontal cortex. Frontal and cingulate
cortices, thalamus, cerebellum and areas of the temporal
and parietal lobes also had increased connectivity
implicating networks that mediate motivation, memory
and learning [56]. By way of contrast, a similar analysis
on internet addiction did not discover any overall
change in topology. Nevertheless, localized increases in
connectivity were routed through the parietal lobe, limbic
system (middle and anterior cingulate cortex) and
thalamus [57], suggesting some overlap in the substrate
of addiction measured by the connectome.
Surface models of the cortex
A mesh representation of the grey matter mantle covering
the cerebral hemispheres can be estimated from the inner
(grey–white boundary) and outer (pial) surfaces. Measures
of cortical thickness, volume and geometry can then be
made that are complementary to volume estimates from
VBM, which is a combination of thickness, surface area
and gyrification [58].
Thinner cortices in cocaine addicts are seen in dorsal
prefrontal and insula cortices, elements of the brain
reward circuit that is also implicated by VBM, and are
accompanied by an overall reduction in cortical volume
[59]. However, amphetamine use is not related directly
to a reduction in cortical thickness, but with comorbid
alcohol consumption when there is thinning in frontal
and pre-central regions [60]. Alcoholism in adults is
itself linked to decreases in cortical thickness in frontal,
pre- and postcentral, temporal and occipital cortical
regions and correlated positively with severity of abuse
[61]. Reduced cingulate cortex and inferior frontal
gyrus thickness in adolescents appear to be predictive
markers for transition to addictive behaviour, when
subcortical and temporal regions are reduced further
[62]. Interestingly, the lateral orbitofrontal cortex is also
reduced in adolescents with internet addiction [63],
indicating some similarities with a predisposition to
alcohol abuse.
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Pharmacological MRI
Pharmacological MRI (phMRI) is used to test how
pharmacological agents modulate brain activation and/or
cognitive performance during an fMRI study. Drugs are
usually given in an acute challenge (i.e. as a single dose
prior to the scanning session), although recently chronic
drug treatment regimens have been used to mimic more
closely the clinical outcome of drug administration [64].
Importantly, the use of phMRI may have some value with
respect to neuroimaging biomarkers for addiction [65].
Here, such challenge studies may be able to demonstrate
that patterns of activation in early drug abstinence are able
to predict whether some addicts are likely to respond to a
particular class of psychotrophic, should it be developed
as a medication for addiction and relapse prevention. The
use of phMRI may allow neuroscience research in the
addictions to make more informed inferences regarding
the neurochemistry of underlying disturbances to
particular cognitive processes in addiction [66–68].
Functional biomarkers for treatment monitoring
Addiction is associated commonly with increased brain
activity to drug-related cues [69–75] and reduced activity
to cues that predict non-drug rewards [76–81], together
with reduced activity in response to the demands of
executive control [41,82–86] and social cognition [87].
Examining neural responses within these domains is of
particular interest with respect to the development of fMRI
biomarkers that identify neural mechanisms for drug
relapse during early abstinence, and for the treatment of
addiction. There may be a common fMRI ‘signature’ across
cognitive domains within loci that may be explored as
potential targets for cognitive [88–90] and/or pharmaco-
logical [71,90–93] therapies in the addictions. This would
be especially significant if distinct neural brain biomarkers
could predict both successful and unsuccessful abstinence
and treatment response.
Studies that have used fMRI to predict relapse and
treatment response have been surprisingly scarce, but
endorse imaging in addiction research. A seminal study
of this type was conducted in methamphetamine addicts
during a decision-making task. Activation patterns in the
insular, posterior cingulate and temporal cortex obtained
in early recovery predicted correctly 90% of participants
who did not relapse and 94% of participants who did
[94]. In a longitudinal study examining neural responses
during reinforcement learning as a predictor of relapse in
methamphetamine addiction, individuals who were
abstinent and then relapsed 1 year later showed greater
prefrontal activation during learning, but attenuated
striatal, insular and frontal activation in response to feed-
back compared with those methamphetamine-dependent
people who remained abstinent [95]. In a study exploiting
the processing of non-drug-related stimuli, higher
activation in the striatum and insula in response to poten-
tially risky rewards during in-patient treatment was found
only in those patients who subsequently remained drug
abstinent [96]. There are also several other studies which
have demonstrated how BOLD activation patterns are able
to predict relapse in addiction populations [97–100].
FMRI has also been used to predict treatment responses
to medications in addiction. In alcoholic patients, the
treatment response to naltrexone has been shown to be
predicted by the level of pre-treatment cue–reactivity in
the ventral striatum in response to alcohol-related cues
[101]. Therefore, while somewhat scarce, there is good
scientific evidence that endorses the use of fMRI for the
identification of potential neural biomarkers for abstinence,
relapse and treatment outcome in addiction. The search for
such fMRI biomarkers is highly desirable as a prelude to the
development of new interventions in addiction.
Future directions
There have been large improvements in MRI technology as
a result of the evolution of precision engineering and
electronics, with a trend towards increases in the static
magnetic field of scanners to 7 T or greater, and the
simultaneous acquisition of MRI data with physiological
information available from radioligand imaging. Optimiza-
tion of existing techniques will certainly yield the expected
improvements in spatial resolution, signal-to-noise and
increased sensitivity [102], as well as the development of
new protocols to detect drug actions.
Quantitative structural relaxometry
In general, MRI scans depicting brain structure are not
associated with SI units and are subject to variations in
scanner hardware and software, environmental changes
in the scanning room and so on, over and above the
physiological variations that may be of interest. This is
problematic for longitudinal MRI assessments and when
combining data in multi-centre studies [103].
Designed for the measurement of absolute values of
relaxation rates, MRI relaxometry makes several rapid
acquisitions systematically varying key parameters.
Variants of the technique have been shown to have
excellent characteristics in comparisons across multiple
scanning centres [104,105], with benefits to all areas of
clinical neuroscience research. Of particular relevance
to addiction, MRI relaxometry also makes possible
quantitative measurement of myelin concentration
through a process known as magnetization transfer.
Protons in water molecules have their magnetic resonance
properties altered by being bound to macromolecules such
as myelin, assumed to be the predominant compound of
this type in the brain, in a way that is related to its
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concentration [106]. We have already seen from diffusion
imaging that white matter degradation is significant in ad-
diction, and that myelin loss may be part of the underlying
process. Magnetization transfer, and MRI relaxometry in
general, provide the means to follow the trajectory of brain
changes reliably during drug-taking, remission and relapse
as a potential predictor of their onset.
Susceptibility weighted venography
Magnetic susceptibility describes the behaviour of a
material when placed in a magnetic field. A good example
of this is shown in both deoxygenated and oxygenated
haemoglobin, which have contrastingmagnetic properties,
and is the physical origin of the BOLD effect. It is also an
effect that is exploited to obtain contrast between deoxy-
genated blood-filled vessels and the surrounding tissue,
and thus visualize the venal system in fine detail [107].
Cardiovascular illness is a major comoribity of addiction
[46], and changes in cerebral blood flow are well known as
a consequence of drug use [108], which may lead to an
increased risk of intra-cerebral haemorrhage [109]
detectable by susceptibility imaging. At increased MRI field
strengths, susceptibility imaging is capable of detecting
vessels < 1 mm in small structures relevant to addiction
research, such as the thalamus [110] and midbrain
[111], with possibilities for a more holistic understanding
of the neurobiology of addiction.
Simultaneous MRI and PET
Most fMRI studies do not consider the problem of reverse
inference; in other words, specific functional significance
ascribed to fMRI activations on the basis of the known
distribution of neurotransmitters and receptors. One
common example of this concerns reports describing
reductions in the BOLD signal in dopamine-rich areas
of the brain (e.g. nucleus accumbens) in response to a
non-drug reward (e.g. money) in an addiction population
that is then attributed to deficits in this particular
neurotransmitter. In fact, fMRI cannot make direct
inferences about the neurochemistry underlying a particu-
lar functional process and how disturbances associated
with addiction are alterations of this neurochemistry.
The advent of combined MRI and PET imaging systems
can potentially overcome this problem. Although very
much in its infancy, PET–MRI has the potential to
demonstrate specifically that reductions in the BOLD signal
in response to a non-drug reward are in brain regions that
are the result of simultaneous and colocated reductions in
dopamine release. Initial PET–MRI studies have already
demonstrated that these complementarymeasures of brain
function can provide new insights into the functional and
structural organization of the brain [112]. This metho-
dology is also likely to revolutionize drug development
strategies in addiction and potentially reduce the high costs
incurred in drug discovery programmes.
CONCLUDING REMARKS
These are pioneering days for the investigation of addiction
with neuroimaging. Individual reports across a wide range
of measures of brain structure and function are often
difficult to reconcile, or even contradictory. However,
where the literature is reasonably well populated a more
convergent picture is developing that encourages
continued effort with the promise of a coherent narrative
for this disorder. Imaging studies paint a picture of
addiction as global changes to brain structure and func-
tional disturbances to frontostriatal circuitry, accompanied
by changes in anterior white matter. However, it is unlikely
that neuroimaging alone will provide the evidence for a
unifying theory of addiction. The wide variety of drugs or
activities that are included within the description of
addiction, and the physical and mental comorbidities that
cause or are caused by addictive behaviours, contribute
to the observed heterogeneity, emphasizing the importance
of sample selection and participant stratification.
It might be argued that before rushing to meet
the future, addiction research might be better served by
consolidating what is already known and available.
Meta-analyses have proved to be a vital tool in other areas
of neuroimaging research, consolidating the evidence and
streamlining the prevailing narrative [113]. Development
of meta-analytical algorithms offer improved sensitivity,
but obviously can only be as convincing as the quality
and quantity of the primary literature permit. Increasing
confidence in the literature on addiction could be
facilitated by larger sample sizes in multi-centre studies,
but also by open access to appropriate imaging data
repositories, following the successes of initiatives for
conditions such as autism [114] and Alzheimer’s
disease [115].
Clearly, MRI imaging is only one part of awider effort to
understand the aetiology and treatment of addiction. For
brevity this review has not made reference to the literature
using magnetic resonance spectroscopy [11] or, indeed,
other imaging modalities. This is not to downplay their
importance. What unites all these techniques, at least in
the short to medium term, is that the greatest advances
may not come from newmeasurements, but from applying
innovations in data processing and computer modelling.
Nevertheless, new techniques will lead to new opportuni-
ties. The monitoring and prediction of abstinence and
relapse are key to supporting clinical decision-making,
and the discovery of biomarkers that are sensitive to
pharmacological or psychological therapies would be a
significant step forward.
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